AUSPEX PHARMACEUTICALS

PRODUCT PIPELINE

Our steadily growing intellectual property estate encompasses improved successors to medicines with combined annual gross sales in excess of $50 billion. Our technology platform ensures the development of a large number of clinical candidates at a reduced cost and with a reduced risk profile.

Auspex has filed patent applications on hundreds of novel therapeutics based on clinically validated drugs. To date, over 65 patent applications have published and we have begun to receive granted patents covering a series of important medicines, some of which are summarized in our development pipeline below. More applications will continue to publish over the next 12-18 months.